Kreon

Pancreatin, the active ingredient in Kreon, is a pancreatic enzyme replacement therapy presented as enteric‑coated delayed‑release capsules for oral use. It treats exocrine pancreatic insufficiency in patients with cystic fibrosis, chronic pancreatitis, pancreatic cancer, and after pancreatectomy.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality medicines across multiple regions, and our global distribution network ensures timely delivery and compliance with local regulatory requirements, and support for pharmacovigilance.

Kreon is used to replace deficient pancreatic enzymes in conditions that cause exocrine pancreatic insufficiency.

Exocrine pancreatic insufficiency due to cystic fibrosis: improves digestion and nutrient absorption by supplying lipase, amylase and protease. Chronic pancreatitis: aids in the breakdown of fats, carbohydrates and proteins, reducing steatorrhea and malnutrition. Pancreatic cancer: supports digestive function when tumor or treatment impairs pancreatic enzyme production. Post‑pancreatectomy: provides essential enzymes to compensate for loss of pancreatic tissue after surgical removal.

Pancreatin may cause a range of adverse reactions, most of which are mild and related to gastrointestinal tolerance.

Common Side Effects: - Abdominal discomfort or pain: mild cramping that usually resolves without treatment. - Flatulence and bloating: increased gas production leading to a feeling of fullness. - Diarrhea or loose stools: frequent watery bowel movements that may cause dehydration if persistent. - Nausea or mild vomiting: sensation of queasiness that can lead to occasional vomiting. - Constipation: difficulty passing stool that may require dietary adjustment.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, swelling, or anaphylaxis: signs of hypersensitivity requiring immediate medical attention. - Severe abdominal pain or pancreatitis exacerbation: intense pain that may indicate worsening pancreatic inflammation. - Intestinal obstruction or blockage: symptoms of severe constipation or abdominal distension needing urgent care. - Fecal incontinence: loss of bowel control that can affect quality of life.

When prescribing Kreon, clinicians should consider several precautionary measures to ensure safe and effective use. - Dose adjustment: individualize dosing based on severity of enzyme deficiency and patient response. - Monitoring: regularly assess nutritional status, weight gain and stool fat content. - Drug interactions: avoid concomitant use of antacids or proton pump inhibitors that may reduce enzyme activity. - Pregnancy and lactation: safety has not been established; use only if potential benefit outweighs risk. - Storage: Store below 25°C: keep in the original pack, protect from moisture.

Pancreatin can interact with certain medications and substances that affect gastric pH or gastrointestinal function.

Major Interactions (Avoid): - Proton pump inhibitors (e.g., omeprazole): raise gastric pH and may reduce enzyme activation. - Antacids containing aluminum or magnesium: can bind pancreatic enzymes and diminish efficacy. - Orlistat: may interfere with the action of pancreatic lipase, reducing fat digestion.

Moderate Interactions (Monitor Closely): - Antibiotics that alter gut flora (e.g., clindamycin): may affect enzyme activity indirectly. - High‑fiber supplements: can bind enzymes and lessen their effectiveness. - Laxatives: may change intestinal transit time, impacting enzyme contact with nutrients.